Dentists in Maybrook, NY Accepting Medicare
1 Dentists found. Showing 1 - 1
 Elizabeth Ban Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 935 Homestead Ave, Maybrook, NY 12543 Phone: 845-427-5419 |
News Archive
People with TBI have significantly more difficulty with gist reasoning
A new study reveals that individuals with traumatic brain injury (TBI) have significantly more difficulty with gist reasoning than traditional cognitive tests. Using a unique cognitive assessment developed by researchers at the Center for BrainHealth at The University of Texas at Dallas, findings published Friday in the Journal of Clinical and Experimental Neuropsychology indicate that an individual's ability to "get the gist or extract the essence of a message" after a TBI more strongly predicts his or her ability to effectively hold a job or maintain a household than previously revealed by traditional cognitive tests alone.
New class of HCV inhibitors discovered by Eiger BioPharmaceuticals
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
No one funding model is sufficient to ensure availability of life-saving drugs
"Trade deals are threatening generic drugs - we need new ways to incentivize affordable drug development," Daniele Dionisio, head of the research project Geopolitics, Public Health and Access to Medicines (GESPAM) and a member of the European Parliament Working Group on Innovation, Access to Medicines and Poverty-Related Diseases, writes in this SciDev.Net opinion piece.
Positive data from Argos Therapeutics' AGS-003 Phase 2 trial for mRCC
Argos Therapeutics today announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium.
Exercise capacity is a powerful predictor of death in patients with coronary artery disease
Exercise capacity, as measured in terms of VO2max, is a powerful predictor of death in patients with coronary artery disease, not just patients with heart failure. That is the finding of a Mayo Clinic study presented at the American Heart Association's Scientific Sessions 2005 in Dallas.
› Verified 6 days ago